Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
innovation tags : Disease save search
Innovent Announces Primary Endpoint Met in the Phase 3 Clinical Trial (RESTORE-1) of IBI311 (Anti-IGF-1R Antibody) in Treating Thyroid Eye Disease and Plans to Submit NDA to the NMPA
Published: 2024-02-20 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.72%
H: 0.0%
C: -0.8%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.53%
H: 0.0%
C: 0.0%
ibi311 disease thyroid eye trial
BD to Present Next Installment of BD Innovates Series: Spotlight on Peripheral Vascular Disease
Published: 2024-02-12 (Crawled : 22:00) - prnewswire.com
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
|
| O: 0.04%
H: 0.72%
C: -1.81%
disease
Merck Highlights Innovative Oncology Portfolio and Pipeline at ESMO Congress 2023 Underscoring Commitment to Advancing Cancer Research and Improving Patient Outcomes Across Multiple Stages of Disease
Published: 2023-10-10 (Crawled : 11:00) - biospace.com/
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: -0.17%
H: 0.13%
C: -0.68%
disease congress merck cancer pipeline research
Innovations in Tonsillitis Disease Landscape Report: DLI's Extensive Disease Insights, Unmet Needs Analysis, KOL Perspectives, Epidemiology Study, and Regulatory Consulting Services | Disease Landscape Insights
Published: 2023-10-03 (Crawled : 10:00) - prnewswire.com
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: -0.62%
H: 1.52%
C: 1.0%
disease services
United States Leads Global Single Use-Disposable Endoscopes Market to 2030: Adoption of Innovations and Chronic Disease Prevalence
Published: 2023-08-31 (Crawled : 23:00) - prnewswire.com
MDT | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: 0.0%
K | $56.54 0.84% 0.0% 1.5M
|
Consumer Non-Durables
|
| O: -0.43%
H: 0.54%
C: -2.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
BSX | $67.42 -0.8% -0.53% 5.9M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: -1.18%
disease global market
New Report Reveals Rare Disease Market Worth US$ 547.5 billion, With CAGR of 13.1% - With Innovative treatments and therapies
Published: 2023-05-11 (Crawled : 10:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
rare disease report market
Philips showcases its latest portfolio of cardiology innovations that deliver clinical confidence and efficiency in treating cardiac disease at EuroPCR 2023
Published: 2023-05-11 (Crawled : 08:00) - globenewswire.com
PHG | $19.98 -0.84% 0.0% 500K
|
Health Technology
|
| O: 2.25%
H: 0.32%
C: 0.05%
disease cardiac cardiology
Innovent Announces First Participant Dosed in Phase 3 Study (RESTORE) of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Eye Disease
Published: 2023-05-08 (Crawled : 00:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.38%
H: 2.06%
C: 1.53%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.03%
H: 0.17%
C: -1.19%
ibi311 disease thyroid eye study
Tonix Pharmaceuticals Presents Non-Clinical Data on TNX-2900 for the Potential Treatment of Hyperphagia in Adolescents and Young Adults with Prader-Willi Syndrome at the Rare Disease Innovation and Partnership Summit
Published: 2023-03-23 (Crawled : 03:00) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 0.24%
H: 3.49%
C: 1.26%
tnx-2900 partnership rare disease innovation treatment pharmaceuticals potential
Tonix Pharmaceuticals Announces Presentation at the Rare Disease Innovation and Partnership Summit
Published: 2023-03-16 (Crawled : 21:00) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 0.1%
H: 2.83%
C: 0.5%
partnership rare disease presentation innovation pharmaceuticals
Ionis Chief Scientific Officer C. Frank Bennett, Ph.D. to receive Rainwater Prize for Outstanding Innovation in Neurodegenerative Disease Research
Published: 2023-01-26 (Crawled : 15:00) - prnewswire.com
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
|
| O: 0.05%
H: 0.58%
C: -0.98%
research disease neurodegenerative innovation
Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease
Published: 2022-12-15 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.78%
H: 0.92%
C: -0.18%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: -0.83%
H: 0.66%
C: 0.3%
treatment disease collaboration
THE NATIONAL ECZEMA ASSOCIATION ROLLS OUT THIS YEAR'S AWARENESS MONTH WITH AN INNOVATIVE FOCUS ON ECZEMA, A LIFE-ALTERING SKIN DISEASE BURDENING OVER 31 MILLION ADULTS AND CHILDREN IN THE USA
Published: 2022-09-30 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: 0.0%
disease children eczema skin
Degenerative Disc Disease Market Size to Grow by USD 1.03 billion, Launch of Innovative Products to be a Key Trend - Technavio
Published: 2022-09-26 (Crawled : 23:00) - prnewswire.com
MDT | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: 0.9%
H: 0.4%
C: -1.43%
disease market
Prometheus Laboratories Announces Partnership with Takeda to Launch CDPATH™, a Personalized Prognostic Tool Advancing Innovation for Crohn's Disease Patients
Published: 2022-09-14 (Crawled : 13:20) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 0.52%
C: 0.15%
partnership disease innovation
Takeda Launches CDPATH™, a Personalized Prognostic Tool, Advancing Innovation for Patients with Crohn's Disease
Published: 2022-09-14 (Crawled : 12:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 0.52%
C: 0.15%
disease innovation
Lyfebulb and CVS Kidney Care® Announce Finalists for 2022 Innovation Challenge in Kidney Disease
Published: 2022-03-15 (Crawled : 13:00) - prnewswire.com
CVS | $69.39 1.15% -0.17% 10M
|
Retail Trade
|
| O: 0.49%
H: 2.33%
C: 1.89%
care kidney disease
Feb. 24: Research Update on Cannabis Disease & Insect Management with Biologicals
Published: 2022-02-16 (Crawled : 00:00) - marronebio.com
MBII | $0.7981 -20.19% 1.49%
|
Process Industries
|
| O: -1.53%
H: 6.09%
C: 2.74%
als cannabis research disease
Star Therapeutics emerges from stealth mode raising $100M in financing since inception to be an innovation engine for rare disease therapies
Published: 2022-02-16 (Crawled : 12:30) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.08%
H: 1.53%
C: 1.04%
rare star therapeutics disease 100 merge
Global $74.9 Bn Small Molecule Innovator CDMO Markets to 2030: Focus on Cardiovascular Disease, Oncology, Respiratory Disorders, Neurology, Metabolic Disorders, & Infectious Diseases
Published: 2022-02-09 (Crawled : 14:30) - prnewswire.com
CTLT | $55.8 -0.29% 0.0% 1M
|
Health Technology
|
| O: 0.87%
H: 1.8%
C: 1.57%
order metabolic respiratory cardio disease cardiovascular infectious disease
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.